Opus Genetics, Inc. (IRD) vs Ocugen, Inc. (OCGN)
A side-by-side comparison of Opus Genetics, Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRD
Opus Genetics, Inc.
$4.42HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
OCGN
Ocugen, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
Total return — IRD vs OCGN
growth of $100 · dividends reinvested · last 2yIRD +239.5% (+84.3%/yr)OCGN +0.0% (+0.0%/yr)IRD compounded faster over this window
IRD OCGN
IRD vs OCGN: by the numbers
- •IRD is the larger company ($365M vs $363M market cap).
- •Both run net losses; IRD's is the smaller (-1091.82% vs -1786.27% net margin).
Metrics side by side
Valuation
| Metric | IRD | OCGN |
|---|---|---|
| P/S ratio | 36.99 | 79.22 |
Profitability
| Metric | IRD | OCGN |
|---|---|---|
| Gross margin | 99.87% | 45.86% |
| Operating margin | -271.90% | -1425.70% |
| Net margin | -1091.82% | -1786.27% |
| ROIC | -59.29% | -93.74% |
Growth (annualized)
| Metric | IRD | OCGN |
|---|---|---|
| Revenue CAGR (5Y) | 150.49% | N/A |
| Total return CAGR (5Y) | N/A | -31.57% |
Go deeper
Dig into the metrics
Opus Genetics ROEOcugen ROEOpus Genetics operating marginOcugen operating marginOpus Genetics revenue growthOcugen revenue growthOpus Genetics free cash flowOcugen free cash flow
Opus Genetics & Ocugen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.